Sugi Predict

Sugi Predict / Compounds / SCHEMBL6318628

SCHEMBL6318628

SCHEMBL6318628

COC(=O)c1ccc2[nH]c(C)c(Cc3ccc(-c4cccs4)cc3Cl)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ HSD17B10 Q99714 3/20 0.43
▸ HPGD P15428 2/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ CASP1 P29466 1/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ ALOX12 P18054 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ ATM Q13315 2/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ PTPN5 P54829 1/20 0.41
▸ MAPT P10636 3/20 0.41
▸ GABRA1 P14867 2/20 0.40
▸ GABRG2 P18507 2/20 0.40
▸ GABRB3 P28472 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6322418 0.90 PTPN5 (0.48) KDM4EALDH1A1HPGDMAPK1MEN1
SCHEMBL5881928 0.86 MEN1 (0.50) KDM4EALDH1A1HSD17B10HPGDNPC1
SCHEMBL6135028 0.83 MAPT (0.42) MAPTTP53
SCHEMBL5881887 0.82 KDM4E (0.50) KDM4EALDH1A1HSD17B10HPGDNPC1
SCHEMBL6319227 0.82 MEN1 (0.44) KDM4EALDH1A1HSD17B10HPGDNPC1
SCHEMBL6327748 0.81 PPARG (0.41) SMN1; SMN2MAPTTP53CNR1
SCHEMBL5882184 0.81 PDE3B (0.56) KDM4EALDH1A1HSD17B10HPGDNPC1
SCHEMBL6319384 0.81 KDM4E (0.48) KDM4EALDH1A1HSD17B10HPGDNPC1
SCHEMBL6322574 0.80 ALDH1A1 (0.46) KDM4EALDH1A1HSD17B10HPGDNPC1
SCHEMBL6317424 0.79 RAB9A (0.45) KDM4EALDH1A1HSD17B10HPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050209278-A1 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors PHARMACIA CORPORATION 2005-09-22 — — US disclosed
US-20050171185-A1 Indole derivatives FUJISAWA PHARMACEUTICAL CO., LTD., A JAPANESE CORPORATION 2005-08-04 — — US disclosed
CN-1150167-C Indole derivatives ����ҩƷ��ҵ��ʽ���� 2004-05-19 — — CN disclosed
CN-1303371-A Indole derivatives FUJISAWA PHARMACEUTICAL CO (JP) 2001-07-11 — — CN disclosed
EP-1070705-A1 INDOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-01-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050209278-A1 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors MMP1, PREP, MMP3 KDM4E 1152/4885ALDH1A1 406/4885HSD17B10 1453/4885
US-20050171185-A1 Indole derivatives PDE5A, IGFBP5, HTR5A KDM4E 942/4885ALDH1A1 293/4885HSD17B10 336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.